Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,135.77
(
0.00%
)
US TECH 100
26,332.80
(
-0.49%
)
Dow Jones
49,321.48
(
0.94%
)
Brent Oil
110.09
(
-2.04%
)
Bitcoin
76,456.00
(
0.90%
)
News Focus
News Focus
Post# of 5031397
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

stock1ace1

Send PM Follow Ignore
Followers 289
Posts 38536
Boards Moderated 2
Alias Born 04/05/2012

stock1ace1

Re: glenn1919 post# 5013052

Tuesday, 09/23/2025 1:55:06 PM

Tuesday, September 23, 2025 1:55:06 PM

Post# of 5031397
DWTX $4.93 pending phase 2 data 1 million float $7 cash per share on balance sheet

Halneuron® Chemotherapy-Induced Neuropathic Pain (“CINP”) Phase 2b study interim data readout remains on track for Q4 2025

Cash on hand of $13.4 million provides operational runway through Q1 2026 -

ATLANTA, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Dogwood Therapeutics, Inc. (Nasdaq: DWTX)
https://finviz.com/news/139096/dogwood-therapeutics-reports-second-quarter-2025-financial-results
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today